Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2000

View Archived Issues

Alkermes and Glaxo Wellcome finalize pulmonary drug delivery agreement

Antex traveler's diarrhea vaccine awarded funding from U.S Army

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

BTG obtains rights for a novel approach to treat malaria

Genzyme General and Genzyme Tissue Repair extend NeuroCell-PD milestone deadline

BioChem Pharma sells share of North American Vaccine

Aviron initiates clinical testing of CMV vaccine

Positive preliminary phase I/II results of HCT-1026 in contact urticaria

Argatroban approved for HIT in U.S.

Systemically administered caspase inhibitor provides neuroprotection in rat model

Aventis and NPS Allelix join together to develop novel, selective dopamine D4 antagonists

Novel NK1 receptor antagonists: synthesis and SAR presented by Merck in Kansas City

New human prolactin receptor antagonist S179D-PRL undergoes extensive biological testing

NC-2100: a new thiazolidinedione with a unique pharmacological profile

Organon's Orgalutran approved in E.U. for treatment of infertility

Elaidic acid ester of ganciclovir as a promising new Rx for herpesvirus infections

Prolifix enters agreement for cell cycle protein research

Synthetic conjugated oral estrogen holds significant promise as HRT for postmenopausal women

Agenerase receives positive opinion from CPMP

Topiramate now claimed effective in schizophrenia

Ferrer's new antihypertensive angiotensin II antagonists prove more potent than losartan

Dual estrogen agonist/antagonist compounds and their use revealed by Akzo Nobel

Potent HCV NS3 protease inhibitors designed at Italian laboratory

Potential new treatments for asthma from Roche act as chemokine receptor antagonists

Peptides useful in toxic shock syndrome discovered by Rockefeller U. researchers

Cancer immunotherapies based on WT-1 and gata-1 peptide epitopes

Patent issued to Meiji Seika covering benzoxazole derivatives and use for treating GI disorders

Naphthalene compounds from Torii promote fibrinolysis and exert antithrombotic activity

Biomira acquires remaining rights to Theratope from Chiron

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...